Qureight core imaging platform deployed within Vicore Phase 2b ASPIRE study of buloxibutid for IPF

Qureight Ltd and Vicore Pharma today announce the implementation of Qureight’s Core Imaging Platform within the global Phase 2b ASPIRE trial investigating buloxibutid in patients with idiopathic pulmonary fibrosis (IPF).

VECTOR LABORATORIES ANNOUNCES PARTNERSHIP WITH BRITISH BIOTECH INNOVATOR ETCEMBLY

Vector Laboratories and Etcembly announce a collaboration to accelerate recombinant antibody therapeutic development. The collaboration combines Vector’s antibody expertise with AI-driven insights from Etcembly’s award-nominated platform.

Velsera Drives Momentum in 2024 with Key Platform Advancements and Strategic Growth

ClearNote Health Earns Approval for Avantect® Pancreatic Cancer Test from New York State Department of Health

ClearNote Health announced New York State has approved its Avantect Pancreatic Cancer Test. The ClearNote Health Laboratory now has its NYSDOH permit, as well as its CLIA certification and CAP accreditation.

ResultsCX Rises to ‘Innovator’ Status in Avasant’s CX Center Business Process Transformation RadarView™ Assessment

Cleveland Clinic Announces the Rollout of Ambience Healthcare’s AI Platform

CluePoints named as Finalist in 2025 ACDM Awards

CluePoints, provider of leading statistical and AI-driven software solutions, has been shortlisted for “Team Excellence in the Management of Clinical Data” at the 2025 ACDM Awards.

Sapio Sciences Expands Leadership Team to Drive Growth

Sapio Sciences today announced key leadership appointments to accelerate drug discovery and redefine AI-driven lab informatics. With the appointment of Mike Hampton as Chief Commercial Officer (CCO) and the launch of a new Scientific Office, Sapio is reinforcing its commitment to scientific and customer-driven innovation.

Bio-IT World Venture, Innovation & Partnering Conference Returns to Boston April 3, 2025 with Expanded AI Focus

The second annual Bio-IT World Venture, Innovation & Partnering Conference, taking place April 3 in Boston, will bring together 200+ venture capitalists, private equity professionals, bankers, government partners, and entrepreneurs who are advancing the growth of the TechBio, biotech, drug discovery and healthcare sectors.

Phastar Secures SCOPE US ‘Best in Show’ Accolade for Clinical Intelligence Platform

Phastar, a global specialist biometrics & data science contract research organization (CRO), won a Best of Show Award at Summit for Clinical Ops Executives (SCOPE) US 2025.

JuliaHub Doubles Investment in Advanced Pharmaceutical Modeling Platform

JuliaHub is doubling its investment in the pharmaceutical sector, leveraging JuliaHub’s new-and-improved CFR Part 11-compliant pharmaceutical platform.

Phreesia’s Sally Thayer Selected as a Top Woman Leader in Software

Phreesia is proud to announce that Sally Thayer, Vice President of Product Management, has been named to The Software Report’s list of the Top 50 Women Leaders in Software of 2024.

GitHub Advanced Security Integrates Endor Labs Software Composition Analysis for End-to-End Application Security

Endor Labs, the leader in open source software security, announced a critical partnership with GitHub, the platform for software developers to create and share code, that makes it easier than ever for application security teams and developers to accurately identify and remediate the most serious security vulnerabilities—all without leaving GitHub.

Pillar VC Expands into UK and Launches Encode, an AI for Science Fellowship

Backed by Pillar VC and powered by the Advanced Research + Invention Agency, the Encode Fellowship will place top AI talent in leading UK research labs to accelerate scientific breakthroughs

Qureight and Avalyn Launch Strategic Partnership in Progressive Pulmonary Fibrosis

A clinical trial for people living with the life-threatening lung condition Progressive Pulmonary Fibrosis (PPF) is using deep learning imaging technology to evaluate a new treatment to tackle the condition for the first time.

Inizio accelerates growth with a trio of strategic leadership appointments

Sapio Sciences Selected by LabConnect to Transform Laboratory Operations

Sapio Sciences today announced that LabConnect has chosen Sapio LIMS (Laboratory Information Management System) to digitally transform complex research workflows, streamline sample tracking, and enhance data management.

Synexa Life Sciences Achieves Highest Level My Green Lab Certification, Reinforcing Commitment to Lab Sustainability

Synexa Life Sciences has achieved the My Green Lab Certification at the highest ‘Green’ level at its Cape Town, South Africa facility.

Schrödinger Selects Sapio Sciences to Enhance In Silico Drug Discovery From Plasmid to Structure

Sapio Sciences today announced that Schrödinger, a global leader in computational chemistry, has adopted the Sapio Platform to improve data management, enhance lab efficiency, and accelerate the discovery of novel molecules. By deploying Sapio’s unified informatics platform, including Sapio LIMS and Sapio ELN, Schrödinger is transforming its recently acquired wet lab operations, integrating data, and streamlining workflows.

ActiGraph and Hyfe announce availability of new digital health tool for cough monitoring

ActiGraph, the global leader in wearable digital health technology for clinical research and drug development, and Hyfe Inc., the pioneer in AI-powered cough detection technology, have announced the release of their new digital health solution for detection of coughs using the ActiGraph LEAP wearable.